The comparison of efficacy between recombinant activated factor VII (Aryoseven®) and Novoseven® in patients with congenital factor VII deficiency

Authors
Category Primary study
JournalJournal of Thrombosis and Haemostasis
Year 2013
This article has no abstract
Epistemonikos ID: 182ab9376c03d29b2f510aae237f7fe3e85567e6
First added on: Feb 05, 2025